These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10854045)

  • 1. The importance of sustained blood pressure control.
    Meredith PA
    J Cardiovasc Pharmacol; 2000; 35 Suppl 3():S7-11. PubMed ID: 10854045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance of blood-pressure-lowering effect following a missed dose of aliskiren, irbesartan or ramipril: results of a randomized, double-blind study.
    Palatini P; Jung W; Shlyakhto E; Botha J; Bush C; Keefe DL
    J Hum Hypertens; 2010 Feb; 24(2):93-103. PubMed ID: 19458624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment.
    Aznaouridis KA; Vyssoulis GP; Karpanou EA; Marinakis AG; Barbetseas JD; Zervoudaki AI; Cokkinos DV; Stefanadis CI
    Blood Press Monit; 2007 Apr; 12(2):87-94. PubMed ID: 17353651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Switching therapy to bedtime for uncontrolled hypertension with a nondipping pattern: a prospective randomized-controlled study.
    Farah R; Makhoul N; Arraf Z; Khamisy-Farah R
    Blood Press Monit; 2013 Aug; 18(4):227-31. PubMed ID: 23660686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twenty-four-hour ambulatory blood pressure evaluation of antihypertensive agents.
    Zanchetti A
    J Hypertens Suppl; 1997 Dec; 15(7):S21-5. PubMed ID: 9532517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to evaluate the duration of blood pressure control: the trough:peak ratio and 24-hour monitoring.
    Meredith PA
    J Cardiovasc Pharmacol; 1998; 31 Suppl 2():S17-21. PubMed ID: 9605597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ambulatory blood pressure parameters after canrenone addition to existing treatment regimens with maximum tolerated dose of angiotensin-converting enzyme inhibitors/angiotensin II type 1 receptor blockers plus hydrochlorothiazide in uncontrolled hypertensive patients.
    Guasti L; Gaudio G; Lupi A; D'Avino M; Sala C; Mugellini A; Vulpis V; Felis S; Sarzani R; Vanasia M; Maffioli P; Derosa G
    Drug Des Devel Ther; 2017; 11():2293-2300. PubMed ID: 28831241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
    Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of spirapril, isradipine, or combination in hypertensive patients with left ventricular hypertrophy: effects on LVH regression and arrhythmogenic propensity.
    Manolis AJ; Beldekos D; Handanis S; Haralabidis G; Hatzissavas J; Foussas S; Cokkinos DV; Bresnahan M; Gavras I; Gavras H
    Am J Hypertens; 1998 Jun; 11(6 Pt 1):640-8. PubMed ID: 9657622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of trough to peak efficacy in the evaluation of antihypertensive therapy.
    Meredith PA
    J Hypertens Suppl; 1998 Jan; 16(1):S59-64. PubMed ID: 9534099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of a missed dose of trandolapril and enalapril on blood pressure control in hypertensive patients.
    Vaur L; Dutrey-Dupagne C; Boussac J; Genes N; Bouvier d'Yvoire M; Elkik F; Meredith PA
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):127-31. PubMed ID: 7564352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 24-hour blood pressure control: its relevance to cardiovascular outcomes and the importance of long-acting antihypertensive drugs.
    Elliott HL
    J Hum Hypertens; 2004 Aug; 18(8):539-43. PubMed ID: 15190262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of verapamil SR, trandolapril, and their fixed combination on 24-h blood pressure: the Veratran Study.
    Veratran Study Group
    Am J Hypertens; 1997 May; 10(5 Pt 1):492-9. PubMed ID: 9160758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of individualized antihypertensive therapy on the blood pressure and left ventricular hypertrophy of hypertensive patients with coronary heart disease].
    Liu TT; Li Y; Yao SY; Wang C; Wang M; Liu J; Shi YJ; Xue H
    Zhonghua Yi Xue Za Zhi; 2019 Apr; 99(13):977-982. PubMed ID: 30955308
    [No Abstract]   [Full Text] [Related]  

  • 18. Using fixed-dose combination therapies to achieve blood pressure goals.
    Chrysant SG
    Clin Drug Investig; 2008; 28(11):713-34. PubMed ID: 18840014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutic importance of home blood pressure assessment and combination antihypertensive therapy for achieving target blood pressure control: Ibaraki hypertension assessment trial.
    Sato A; Watanabe S; Okubo S; Toi T; Doi T; Nakano H; Tada J; Aonuma K;
    Hypertens Res; 2010 Dec; 33(12):1264-71. PubMed ID: 20927115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
    Tytus RH; Burgess ED; Assouline L; Vanjaka A
    Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.